Predictably Human
Predictably Human: Advancing precision therapeutics through tech-enabled dosing, monitoring, and digital interventions.
Founded
2020Predictably Human: Advancing precision therapeutics through tech-enabled dosing, monitoring, and digital interventions.
Predictably Human, founded with the mission to revolutionize precision therapeutics, focuses on leveraging technology to enhance drug dosing, adherence, patient monitoring, and digital interventions. The company aims to treat chronic diseases and addiction, with its initial application targeting nicotine dependence. Their flagship product, NoMore, is an individualized and adaptive drug delivery device integrated with a personalized digital companion, designed to provide coordinated and personalized therapies at scale.
Notable figures affiliated with Predictably Human include experts in digital health and precision medicine. The company has garnered attention from investors interested in innovative healthcare solutions. Key achievements include the development and deployment of the NoMore device, which has shown promise in improving patient outcomes through precise and adaptive treatment protocols. Predictably Human's impact lies in its potential to transform chronic disease management and addiction treatment through advanced digital therapeutics.
Companies similar to Predictably Human include Behaivior, Miist Therapeutics, Perx Health and Better Therapeutics.
Predictably Human was founded in 2020.
Predictably Human's headquarters is located in Westport, CT, US.
Predictably Human's most recent funding round was for $1.7M (USD) in April 2021.
As of Apr 15, 2021, Predictably Human has disclosed funding of $1.7M (USD). Undisclosed round amounts are excluded.
Predictably Human has 6 employees as of Feb 5, 2024.
Better Therapeutics
